These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27488345)

  • 21. Differential effects of subtype-specific nicotinic acetylcholine receptor agonists on early and late hippocampal LTP.
    Kroker KS; Rast G; Rosenbrock H
    Eur J Pharmacol; 2011 Dec; 671(1-3):26-32. PubMed ID: 21968142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional alpha7 nicotinic receptors are expressed on immature granule cells of the postnatal dentate gyrus.
    John D; Shelukhina I; Yanagawa Y; Deuchars J; Henderson Z
    Brain Res; 2015 Mar; 1601():15-30. PubMed ID: 25553616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholinergic nicotinic systems in Alzheimer's disease: prospects for pharmacological intervention.
    Vesey R; Birrell JM; Bolton C; Chipperfield RS; Blackwell AD; Dening TR; Sahakian BJ
    CNS Drugs; 2002; 16(7):485-500. PubMed ID: 12056923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. α7-nicotinic acetylcholine receptor agonists for cognitive enhancement in schizophrenia.
    Freedman R
    Annu Rev Med; 2014; 65():245-61. PubMed ID: 24111888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding the Bases of Function and Modulation of α7 Nicotinic Receptors: Implications for Drug Discovery.
    Corradi J; Bouzat C
    Mol Pharmacol; 2016 Sep; 90(3):288-99. PubMed ID: 27190210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aging Affects Nicotinic Acetylcholine Receptors in Brain.
    Utkin YN
    Cent Nerv Syst Agents Med Chem; 2019; 19(2):119-124. PubMed ID: 30894113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholinergic System and Neuroinflammation: Implication in Multiple Sclerosis.
    Di Bari M; Di Pinto G; Reale M; Mengod G; Tata AM
    Cent Nerv Syst Agents Med Chem; 2017; 17(2):109-115. PubMed ID: 27550615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. α7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles.
    Medeiros R; Castello NA; Cheng D; Kitazawa M; Baglietto-Vargas D; Green KN; Esbenshade TA; Bitner RS; Decker MW; LaFerla FM
    Am J Pathol; 2014 Feb; 184(2):520-9. PubMed ID: 24269557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The therapeutic potential of α7 nicotinic acetylcholine receptor (α7 nAChR) agonists for the treatment of the cognitive deficits associated with schizophrenia.
    Beinat C; Banister SD; Herrera M; Law V; Kassiou M
    CNS Drugs; 2015 Jul; 29(7):529-42. PubMed ID: 26242477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo.
    Timmermann DB; Grønlien JH; Kohlhaas KL; Nielsen EØ; Dam E; Jørgensen TD; Ahring PK; Peters D; Holst D; Christensen JK; Malysz J; Briggs CA; Gopalakrishnan M; Olsen GM
    J Pharmacol Exp Ther; 2007 Oct; 323(1):294-307. PubMed ID: 17625074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotinic systems in central nervous systems disease: degenerative disorders and beyond.
    Newhouse PA; Kelton M
    Pharm Acta Helv; 2000 Mar; 74(2-3):91-101. PubMed ID: 10812945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restoring long-term potentiation impaired by amyloid-beta oligomers: comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists.
    Kroker KS; Moreth J; Kussmaul L; Rast G; Rosenbrock H
    Brain Res Bull; 2013 Jul; 96():28-38. PubMed ID: 23639920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system.
    Taly A; Corringer PJ; Guedin D; Lestage P; Changeux JP
    Nat Rev Drug Discov; 2009 Sep; 8(9):733-50. PubMed ID: 19721446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Potential of α7 Nicotinic Acetylcholine Receptors.
    Bertrand D; Lee CH; Flood D; Marger F; Donnelly-Roberts D
    Pharmacol Rev; 2015 Oct; 67(4):1025-73. PubMed ID: 26419447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. α7 Nicotinic Acetylcholine Receptor: A Potential Target in Treating Cognitive Decline in Schizophrenia.
    Jones C
    J Clin Psychopharmacol; 2018 Jun; 38(3):247-249. PubMed ID: 29505470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha7 Nicotinic Receptors as Therapeutic Targets in Schizophrenia.
    Tregellas JR; Wylie KP
    Nicotine Tob Res; 2019 Feb; 21(3):349-356. PubMed ID: 30137618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.
    Dani JA; Bertrand D
    Annu Rev Pharmacol Toxicol; 2007; 47():699-729. PubMed ID: 17009926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Review of the Cholinergic System and Therapeutic Approaches to Treat Brain Disorders.
    Bertrand D; Wallace TL
    Curr Top Behav Neurosci; 2020; 45():1-28. PubMed ID: 32451956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innate Immunity and Inflammation Post-Stroke: An α7-Nicotinic Agonist Perspective.
    Neumann S; Shields NJ; Balle T; Chebib M; Clarkson AN
    Int J Mol Sci; 2015 Dec; 16(12):29029-46. PubMed ID: 26690125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive modulators of the α7 nicotinic receptor against neuroinflammation and cognitive impairment in Alzheimer's disease.
    Echeverria V; Yarkov A; Aliev G
    Prog Neurobiol; 2016 Sep; 144():142-57. PubMed ID: 26797042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.